Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Other Accumulated Expenses (2020 - 2026)

IceCure Medical has reported Other Accumulated Expenses over the past 7 years, most recently at $787000.0 for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $787000.0; the TTM value through Mar 2026 reached $787000.0, changed N/A, while the annual FY2025 figure was $1.1 million, 10.51% down from the prior year.
  • Other Accumulated Expenses was $787000.0 for Q1 2026 at IceCure Medical, down from $1.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.5 million in Q4 2022 and bottomed at $787000.0 in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $1.1 million (2025), against an average of $1.5 million.
  • Year-over-year, Other Accumulated Expenses crashed 73.37% in 2023 and then surged 33.37% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $3.5 million in 2022, then tumbled by 73.37% to $920000.0 in 2023, then surged by 33.37% to $1.2 million in 2024, then dropped by 10.51% to $1.1 million in 2025, then dropped by 28.32% to $787000.0 in 2026.
  • The last three reported values for Other Accumulated Expenses were $787000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q4 2024) per Business Quant data.